Fact checked by Jennifer Klump Key Takeaways A phase 2 clinical trial found that combining semaglutide with the antibody ...
New research challenges fears about Ozempic weight regain. Cleveland Clinic study of 8,000 patients finds minimal rebound after stopping GLP-1 medications.
A new Cleveland Clinic study of nearly 8,000 patients found that people who stop popular GLP-1 weight-loss drugs often avoid ...
Study reveals weight-loss jabs may alleviate symptoms of anxiety and depression - Semaglutide linked to lowering rates of ...
From a diabetes drug to a global weight-loss phenomenon, semaglutide has reshaped modern medicine. As patents expire, cheaper ...
For anxiety and depression that co-occur with diabetes and obesity, semaglutide and, to a lesser extent, liraglutide might be ...
Researchers found that the odds of developing an eye condition that leads to vision loss were about 5 times higher among ...